By Steve Groth, CSP, ARM & Cedric Donaldson, DPT, CLCS

How many claims are possible when an employee transfers a patient or resident? The answer is two: both professional liability and workers’ compensation claims can occur simultaneously. What if the individual is an assistant of two? Then there is potential for three claims as the workers’ compensation exposure doubles!

Healthcare and senior living providers are much different from a manufacturer or distributor. People are not inanimate objects like boxes; therefore, the process of determining transfer and mobility needs can be challenging.

In addition, consistency across multiple locations and therapists can vary if standardized processes are not in place. Providers who establish simple, consistent processes often see a reduction in falls, skin tears, bruising, and employee musculoskeletal disorders.

INSURICA’s Approach

  1. Help clients perform a gap analysis of current processes.
  2. Provide guidance and best practices that have worked in similar care environments.
  3. Assist the client in developing their own standardized processes that are feasible for their unique environment.

We recommend simple, objective criteria to be incorporated into the assessment process. Our goal of protecting people also supports other goals such as promoting independence, quality of life, and dignity. Here are two examples:

Fall Risks

The 30-second chair-stand assessment is one possible tool to use to identify potential fall risks related to patient transfers.

See the following resource from the CDC: https://www.cdc.gov/steadi/pdf/STEADI-Assessment-30Sec-508.pdf

Gait Belt/Pivot Transfers

Patients and residents must have a minimum level of strength, mobility, and independence in order for these patient transfers to be done safely. Sample criteria include:

  • Able to sit unassisted.
  • Can take three steps forward and three steps back.
  • Bears weight throughout the entire transfer (four or more seconds).

Insurance is just the transfer of risk for a premium; therefore, to pay less insurance, we need to transfer less risk. INSURICA will highlight these best practices as we write your client profile and advocate for you in the insurance marketplace.

About the Authors

Steve Groth, CSP, ARM – 12 years implementing safe patient/resident handling and mobility programs; 4 years in commercial underwriting for healthcare and senior living clients

Cedric Donaldson, DPT, CLCS – 13 years as a Doctorate in Physical Therapy in a variety of settings: long-term care, post-acute care, home healthcare, and hospice.

This is not intended to be exhaustive nor should any discussion or opinions be construed as legal advice. Readers should contact legal counsel or an insurance professional for appropriate advice. 

About the Author

INSURICA
INSURICA

Share This Story

Stay Updated

Subscribe to the INSURICA blog and receive the latest news direct to your inbox.

Related Blogs

Fiduciary Responsibilities for Employer Health Plans: What Employers Should Know Now

March 6th, 2026|Blog, Employee Benefits|

When employers think about fiduciary responsibility, retirement plans often come to mind first. But recent developments make it clear that fiduciary duties also matter—sometimes significantly—when it comes to employer-sponsored health and welfare plans.

The New Era of Mental Health Parity Enforcement in 2026

March 5th, 2026|Blog, Employee Benefits|

Federal agencies have made mental health parity enforcement a top priority in 2026, and employers sponsoring group health plans are feeling the impact. Regulators are no longer satisfied with high‑level assurances that plans comply with the Mental Health Parity and Addiction Equity Act (MHPAEA). Instead, they expect detailed, data‑driven documentation showing that mental health and substance‑use‑disorder benefits are truly comparable to medical and surgical benefits. This includes not only the written plan design but also how rules are applied in real‑world scenarios.

The 2026 Specialty Drug Surge: What Employers Need to Prepare For

March 3rd, 2026|Blog, Employee Benefits|

Specialty drugs have been a major cost driver for years, but 2026 marks a significant shift in both scale and urgency. With GLP 1 medications expanding into new indications, gene therapies entering the market at record pace, and oncology drugs continuing to rise in both cost and utilization, specialty medications are projected to account for more than 60% of total pharmacy spending this year. That’s a dramatic change for employers, especially considering that specialty drugs represent fewer than 5% of total prescriptions.

Go to Top